COVID-19 vaccine tested at Emory is safe, generates immune response, early results show

COVID-19 vaccine tested at Emory is safe, generates immune response, early results show

An investigational vaccine designed to protect against COVID-19 was generally well tolerated and resulted in production of both binding and neutralizing antibodies in healthy adult volunteers, according to early results of an ongoing phase 1 trial.



Video »

How customized antibiotic combinations could defeat 'superbugs'

A sneaky form of antibiotic resistance called "heteroresistance" is more widespread than previously appreciated. But tracking heteroresistance might guide the choice of antibiotic combinations that can defeat bacteria regarded as invincible.